Ardelyx (ARDX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 10/30/25
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate UpdateGlobeNewsWire • 10/30/25
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology's 2025 Annual MeetingGlobeNewsWire • 10/28/25
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney WeekGlobeNewsWire • 10/21/25
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial OfficerGlobeNewsWire • 10/13/25
Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference TranscriptSeeking Alpha • 09/03/25
Ardelyx (ARDX) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/04/25
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 08/04/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXPRNewsWire • 06/22/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXGlobeNewsWire • 06/18/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ardelyx, Inc. - ARDXGlobeNewsWire • 06/06/25
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources OfficerGlobeNewsWire • 06/02/25
ATTENTION ARDX Investors: Securities Fraud Investigation Underway - Contact Levi & KorsinskyAccesswire • 05/14/25
An Investigation Has Commenced on Behalf of Ardelyx, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your ARDX LossesAccesswire • 05/13/25